When added to statin therapy in patients with diabetes, ezetimibe provides greater cardiovascular protection than what is seen in individuals without diabetes.
Read More »Beta-blockers Effect on Patients Who Have Diabetes and Chronic Heart Failure
Protecting the heart and helping to reduce mortality, a closer look at beta-adrenoceptor inhibition in diabetes.
Read More »Improving Cardiovascular Outcomes with Better Cholesterol Control
Does adding Zetia to a multifaceted drug therapy regimen help improve health outcomes?
Read More »How Does Empagliflozin Reduce Cardiovascular Mortality In Type 2 Patients, Including Those With PAD?
The answer comes from a mediation analysis of the EMPA-REG OUTCOME Trial.
Read More »Common Causes of Death Among Patients with Both Diabetes and ASCVD
Identifying causes of death and related risk factors in patients with type 2 diabetes and cardiovascular disease may help with prevention.
Read More »Real-World Benefits for SGLT-2 Inhibitors
Patients with type 2 diabetes usually do not die from diabetes, but from cardiovascular disease and strokes.
Read More »Are Statins Related to Diabetes Progression?
Statin therapy may be elevating risk of type 2 diabetes in high-risk adults.
Read More »Calcium Score Predicts Future Heart Attack and Stroke Risk
Coronary artery calcium (CAC) scores better at predicting risk of cardiovascular disease (CVD) event in patients with type 2 than traditional scores.
Read More »Hypoglycemia Linked to Increased Risk of Cardiovascular Dysfunction
Severe hypoglycemia in type 2 diabetes was found to be associated with increased cardiac failure and mortality.
Read More »Effect of Pioglitazone on Left Ventricular Diastolic Function
Diastolic function begins to decline in early stages of type 2 diabetes.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.